Piper Sandler reduced its price target on Jazz Pharmaceuticals to $163, maintaining an Overweight rating.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing
Piper Sandler reduced its price target on Jazz Pharmaceuticals to $163, maintaining an Overweight rating.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing